NHS England Reassesses Transgender Treatments Amid Controversy Over Evidence
Following a critical report by Dr. Hilary Cass, NHS England is reevaluating transgender care protocols, emphasizing the need for robust evidence and caution in treating minors.
- Dr. Hilary Cass's report criticizes the existing evidence supporting transgender treatments for children, leading to a comprehensive review by NHS England.
- The report highlights a lack of reliable data on the long-term effects of puberty blockers and hormone therapies, advocating for a pause in their use among minors.
- Medical professionals express concerns about the rapid decision-making process in prescribing hormone treatments to children, citing inadequate assessments.
- Critics argue that current gender care practices are influenced by ideology rather than solid medical evidence, prompting calls for an evidence-based approach.
- The controversy has sparked a broader debate on the treatment of gender dysphoria in children, with various stakeholders pushing for significant changes in clinical guidelines.
The Economist 
The Guardian 
The Daily Caller 
Evening Standard 
The Telegraph 
Blaze Media Evening Standard 
The Daily Signal 
Sky News The Telegraph 
Associated Press Evening Standard Sky News Evening Standard Evening Standard Evening Standard 
NBC News Evening Standard The Telegraph 
Le Monde 
Breitbart Evening Standard The Guardian 
Al Jazeera 
The Seattle Times The Telegraph The Guardian The Guardian The Guardian The Guardian The Telegraph Sky News Sky News The Telegraph The Telegraph The Guardian The Telegraph The Telegraph 